Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

141.51USD
17 Apr 2014
Price Change (% chg)

$-0.35 (-0.25%)
Prev Close
$141.86
Open
$141.98
Day's High
$144.07
Day's Low
$140.29
Volume
2,974,766
Avg. Vol
3,905,055
52-wk High
$174.66
52-wk Low
$110.53

Search Stocks
ALLES MARK J
Trading Date Type Shares Traded Price Shares Held
30 Jul 2013 Buy 2,500 $50.36 17,560
30 Jul 2013 Buy 5,000 $57.80 17,560
30 Jul 2013 Buy 4,875 $73.55 17,560
30 Jul 2013 Buy 3,657 $58.53 17,560
30 Jul 2013 Buy 3,438 $39.01 17,560
30 Jul 2013 Buy 3,437 $54.55 17,560
12 Apr 2013 Buy 4,583 $0.00 7,560
12 Apr 2013 Sell 1,791 $123.00 7,560

Institutional Holders

% Shares Owned: 84.45%
# of Holders: 1,265
Total Shares Held: 342,896,405
3 Mo. Net Change: -859,664
# New Positions: 12
# Closed Positions: 12
# Increased Positions: 66
# Reduced Positions: 83
# Net Buyers: -17

Officers & Directors

Name Age Since Current Position

Robert Hugin

58 2011 Chairman of the Board, Chief Executive Officer

Jacqualyn Fouse

52 2012 Chief Financial Officer, Executive Vice President

Perry Karsen

58 2012 Chief Operations Officer, Executive Vice President

Lawrence Stein

63 2012 Executive Vice President, General Counsel, Corporate Secretary

Mark Alles

54 2012 Executive Vice President, Chief Commercial Officer

Thomas Daniel

59 2012 Executive Vice President, President - Research and Early Development

Michael Casey

67 2007 Lead Independent Director

Richard Barker

64 2012 Independent Director

Carrie Cox

56 2009 Independent Director

Rodman Drake

71 2006 Independent Director

Michael Friedman

69 2011 Independent Director

Gilla Kaplan

66 1998 Independent Director

James Loughlin

70 2007 Independent Director

Ernest Mario

75 2007 Independent Director
Search Stocks